Page last updated: 2024-10-25

clioquinol and Ovarian Neoplasms

clioquinol has been researched along with Ovarian Neoplasms in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, WQ1
Yu, HJ1
Lind, SE1

Other Studies

1 other study available for clioquinol and Ovarian Neoplasms

ArticleYear
Zinc-binding compounds induce cancer cell death via distinct modes of action.
    Cancer letters, 2008, Nov-28, Volume: 271, Issue:2

    Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Clioquinol; Ethylenediamines; Female; Humans; NF-kap

2008